Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
11/13/2020
Recent Executive Moves
11/13/2020
What to Expect in China's 14th Five Year Plan? Decoding the Fifth Plen...
11/12/2020
NMPA Solicits Comments on Draft Provisions for Supervision and Adminis...
11/12/2020
Apollomics Granted IND Approval for APL-102 to Initiate a Phase 1 Stud...
11/12/2020
Takeda, OrigiMed to Develop Genomic-based Clinical Treatment Platform
11/11/2020
SAMR Releases Draft Anti-Monopoly Rules To Scrutinize Online Platforms...
11/11/2020
NHSA Concludes Product Adjustment Evaluation of 2020 NDRL
11/11/2020
Pfizer Inks Deal with Dynamiker
11/11/2020
CStone Announces NMPA Acceptance of Its NDA for Sugemalimab in Firs...
11/11/2020
Nicox Begins 2nd P3 Trial of NCX 470 for Open-angle Glaucoma or Ocular...
11/10/2020
Ambrx Closes US$200M Crossover Financing Round
11/10/2020
CDE Issues the Pharmaceutical Dossiers Requirements for Communication ...
11/10/2020
Innovent Reports on Phase 1a Results of CD47 mAb (Letaplimab) for Ad...
11/9/2020
Eisai Gains Chinese Approval for 2nd Indication of Lenvima® (Lenvatin...
11/9/2020
EUSA Pharma and BeiGene Announce BLA Acceptance for QARZIBA in China
11/9/2020
Three Considerations for Businesses in China When Hiring Technology Ta...
11/7/2020
XTANDI (Enzalutamide Soft Caps) Approved in China for nmCRPC
11/7/2020
Roche China CEO Vows Win-win Collaboration with Local Partners
11/7/2020
AstraZeneca Saw Q3 Slowdown as It Signs Partnership Deal with OM Pharm...
11/7/2020
SK Biopharma Sees Promising Outlook of Its Epilepsy Drug XCOPRI in Asi...
11/7/2020
Thermo Fisher to Build New Pharma Services Facility in China
11/6/2020
Eli Lilly and JD Enter Deal for Online Access of Diabetes New Drug Tru...
11/6/2020
Apollomics Closes $124 Million Series C Financing
11/5/2020
Asieris Approved of P3 Trial of Its Novel Single Oral Agent as First-l...
11/4/2020
MIIT and NHC Issues Joint Notice for Stepping Up the Infrastructure Bu...
11/4/2020
Samsung Bio and GeneQuantum Enter Partnership for Anticancer ADC Drug...
11/3/2020
JW Therapeutics Launches IPO on Hong Kong Stock Exchange
11/3/2020
Xinhua: Roche to Push for Innovative Medicines, Digital Tools in China
11/2/2020
Review of Chemical Drug Sales in Chinese Urban Public Hospitals H1/202...
11/2/2020
Snapshot of Cardiovascular Drug Sales in Chinese Urban Pharmacies 2019
Page:
80
/
333
Total number of articles:
9989
:
[First]
[<<]
[78]
[79]
[80]
[81]
[82]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit